General
Preferred name
AMINOBENZOIC ACID
Synonyms
POTASSIUM p-AMINOBENZOATE ()
para-Aminobenzoic acid ()
4-Aminobenzoic acid ()
PABA ()
Vitamin Bx ()
Vitamin H1 ()
p-Aminobenzoic acid ()
PAB ()
4-Aminobenzoic Acid (sodium salt) ()
AMINOBENZOATE POTASSIUM ()
4-aminobenzoate ()
Benzoic acid, 4-amino ()
NSC-7627 ()
Sodium Aminobenzoate ()
AMINOBENZOATE SODIUM ()
P&D ID
PD008010
CAS
150-13-0
138-84-1
555-06-6
54287-22-8
Tags
natural product
drug
drug candidate
available
Drug Status
approved
experimental
Drug indication
Analgesic,Ultraviolet Screen
Analgesic
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
14
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
85
Properties
(calculated by RDKit )
Molecular Weight
137.05
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
1
Ring Count
1
Aromatic Ring Count
1
cLogP
0.97
TPSA
63.32
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.57
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
Endogenous Metabolite
Indication
scleroderma, dermatomyositis, Peyronie's disease
Disease Area
rheumatology, urology
Pathway
Metabolic Enzyme/Protease
Source data
